Statin use in patients with chronic kidney disease stages 2-4: Targeting beyond improved mortality rates

International Urology and Nephrology

Volumn 42, Issue 3, 2010, Pages 711-713

  Paraskevas, Kosmas I ^d   Tzovaras, Alexandros A ^a   Stathopoulos, Vassilios ^b   Mikhailidis, Dimitri P ^c  

^a Agios Savvas Cancer Hospital   (Greece)

^b General Hospital of Rhodos   (Greece)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; PRAVASTATIN; VITAMIN D;

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; EDITORIAL; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTRIGLYCERIDEMIA; KIDNEY FUNCTION; MORTALITY; TREATMENT RESPONSE;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY DISEASES; VITAMIN D;

EID: 78549293245     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9677-z     Document Type: Editorial

References (20)

1. PL Neves A Malho A Cabrita, et al. 2009 Statins and vitamin D: a friendly association in pre-dialysis patients Int Urol Nephrol 10.1007/s11255-009-9634-x 19763871
2. ME Molitch 2006 Management of dyslipidemias in patients with diabetes and chronic kidney disease Clin J Am Soc Nephrol 1 1090 1099 1:CAS:528: DC%2BD28XpvFOqtr4%3D 10.2215/CJN.00780306 17699330
3. D Banerjee G Contreras I Jaraba, et al. 2009 Chronic kidney disease stages 3-5 and cardiovascular disease in the veterans affairs population Int Urol Nephrol 41 443 451 10.1007/s11255-008-9514-9 19117116
4. KB Meyer AS Levey 1998 Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on cardiovascular disease J Am Soc Nephrol 9 12 Suppl S31 S42 1:STN:280:DC%2BD3MzovF2ksw%3D%3D 11443766
5. M Tonelli C Isles GC Curhan, et al. 2004 Effect of pravastatin on cardiovascular events in people with chronic kidney disease Circulation 110 1557 1563 1:CAS:528:DC%2BD2cXnsVKqu70%3D 10.1161/01.CIR.0000143892.84582.60 15364796 (Pubitemid 39297976)
6. FM Sacks MA Pfeffer LA Moye, et al. 1996 The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1001 1009 1:CAS:528:DyaK28XmsFWls7c%3D 10.1056/NEJM199610033351401 8801446 (Pubitemid 26338729)
7. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group 1998 Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 339 1349 1357 10.1056/NEJM199811053391902 (Pubitemid 28509344)
8. J Shepherd SM Cobbe I Ford, et al. 1995 Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group N Engl J Med 333 1301 1307 1:CAS:528: DyaK28Xhslemsw%3D%3D 10.1056/NEJM199511163332001 7566020
9. C Wanner V Krane W März, et al. 2005 Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 238 248 1:CAS:528:DC%2BD2MXmt1Kms7s%3D 10.1056/NEJMoa043545 16034009 (Pubitemid 41058323)
10. K Farbakhsh BL Kasiske 2005 Dyslipidemias in patients who have chronic kidney disease Med Clin North Am 89 689 699 10.1016/j.mcna.2004.11.002 15755473 (Pubitemid 40332403)
11. KI Paraskevas 2008 Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering Int Urol Nephrol 40 165 170 1:CAS:528: DC%2BD1cXjsVGjt74%3D 10.1007/s11255-007-9307-6 18066677
12. S Gelev G Spasovski S Dzikova, et al. 2008 Vascular calcification and atherosclerosis in hemodialysis patients: what can we learn from the routine clinical practice? Int Urol Nephrol 40 763 770 1:CAS:528:DC%2BD1cXptVChsrY%3D 10.1007/s11255-008-9379-y 18584302
13. F Turgut M Kanbay MR Metin, et al. 2008 Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis Int Urol Nephrol 40 1075 1082 1:CAS:528:DC%2BD1cXhtlCjur%2FE 10.1007/s11255-008-9410-3 18568412
14. M Civilibal H Oflaz S Caliskan, et al. 2009 Left ventricular systolic and diastolic function and carotid intima-media thickness in pediatric dialysis patients Int Urol Nephrol 41 401 408 10.1007/s11255-008-9438-4 18690547
15. VG Athyros AA Papageorgiou M Elisaf DP Mikhailidis GREACE Study Collaborative Group 2003 Statins and renal function in patients with diabetes mellitus Curr Med Res Opin 19 615 617 1:CAS:528:DC%2BD3sXpt1eitrc%3D 10.1185/030079903125002315 14606984 (Pubitemid 37288068)
16. VG Athyros DP Mikhailidis AA Papageorgiou, et al. 2004 The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study J Clin Pathol 57 328 334 10.1136/jcp.2003.012989 (Pubitemid 38901488)
17. VG Athyros M Elisaf AA Papageorgiou GREACE Study Collaborative Group, et al. 2004 Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study Am J Kidney Dis 43 589 599 1:CAS:528:DC%2BD2cXjsFegt70%3D 10.1053/j.ajkd.2003.12.023 15042535 (Pubitemid 38401873)
18. J Rysz WS Aronow RS Stolarek, et al. 2009 Nephroprotective and clinical potential of statins in dialyzed patients Expert Opin Ther Targets 13 541 550 1:CAS:528:DC%2BD1MXltVOmurs%3D 10.1517/14728220902882130 19368496
19. F Youssef P Gupta AM Seifalian, et al. 2004 The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease Angiology 55 53 62 10.1177/000331970405500108 14759090
20. ME Alnaeb F Youssef DP Mikhailidis, et al. 2006 Short-term lipid-lowering treatment with atorvastatin improves renal function but not renal blood flow indices in patients with peripheral arterial disease Angiology 57 65 71 1:CAS:528:DC%2BD2sXmt1egsro%3D 10.1177/000331970605700109 16444458